Microsoft Pri0
Welcome to Microsoft Pri0: That's Microspeak for top priority, and that's the news and observations you'll find here from Seattle Times reporter Sharon Chan.
November 7, 2007 5:18 PM
Potential rival to Enbrel on the horizon
Posted by Angel Gonzalez
An experimental arthritis therapy known as golimumab showed promising results in a late-stage clinical study for the treatment of psoriatic arthritis, Johnson & Johnson unit Centocor and Schering-Plough said Wednesday. The data signals the potential appearance of a new rival to Enbrel, the best-selling treatment developed in Seattle by Immunex and now sold by Amgen.
The compound is designed to be administered less frequently than Enbrel and Abbott Laboratories' Humira (one injection a month, instead of one a week for Enbrel and one every two weeks for Humira). The therapy constitutes an "incremental improvement" over Enbrel and other similar drugs, said Dr. Philip Mease, chief of the Swedish Medical Center's Division of Rheumathology Research in Seattle. Dr. Mease served as an investigator in the trial.
Jul 1, 08 - 11:45 AM
Microsoft buying natural-language search company Powerset
Jun 30, 08 - 05:16 PM
Report: Microsoft to cut Xbox 360 price ahead of big industry event
Jun 27, 08 - 03:52 PM
Gates send-off: Gates has had Ballmer's back from the beginning
Jun 27, 08 - 01:09 PM
Gates send-off: Photos
Jun 27, 08 - 11:48 AM
Gates send-off: Two guys and 90,000 employees

shopping

events for Monday, Jul. 6th
- Alhambra July Sale
- Seattle Premium Outlets July 4th Summ...
- Impulse + Totokaelo Spring Inventory...
- Market Street Shoes and Market Street...
editors' picks
- Garden furnishings
- Outdoors and sporting goods stores
- Top spots for tea
- Vintage, consignment and used clothing

- Seattle may allow homeowners to build backyard cottages
- Landmark Smith Tower mostly vacant
- Police: McNair's girlfriend bought gun Thursday
- Mariners Blog | What the Seattle Mariners learned on their road trip
- Property taxes: Appeals shoot up in King, Snohomish Counties
- Climber who died in fall was Duvall woman
- New laws help tenants evicted due to foreclosure
- Palin links resignation to 'higher calling' and blasts media in Facebook posting
- Former NFL MVP McNair killed
- Hard times for tourist towns means good deals for travelers
- Seattle may allow homeowners to build backyard cottages
- Property taxes: Appeals shoot up in King, Snohomish Counties
- Researchers stunned by inmates' success raising endangered frogs
- Hard times for tourist towns means good deals for travelers
- Landmark Smith Tower mostly vacant
- 250 gather in field near Twisp for fairy congress
- New laws help tenants evicted due to foreclosure
- Microsoft warns of serious computer security hole
- Plasma and LCD beware; OLED screens ready to go mainstream
- Home sales climb in June in King County; median price drops from year ago to $395,000

July
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 |
Bill Gates, who last week ended his full-time involvement with Microsoft, was often right. He made a career, a company and an industry by looking over the horizon.


